Immediate Impact
43 standout
Citing Papers
Antibody–Drug Conjugates (ADCs): current and future biopharmaceuticals
2025 Standout
Novel strategies to manage CAR-T cell toxicity
2025 Standout
Works of Gregory P. Kaufman being referenced
Retrospective, single-center, real-world experience of belantamab mafodotin in relapsed/refractory multiple myeloma.
2022
Human herpesvirus 6 myelitis after chimeric antigen receptor T-cell therapy
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Gregory P. Kaufman | 368 | 170 | 137 | 218 | 26 | 500 | |
| Steven R. Schuster | 406 | 251 | 166 | 189 | 24 | 529 | |
| Mark Offer | 457 | 127 | 160 | 130 | 17 | 497 | |
| Tobias Dittrich | 372 | 113 | 164 | 119 | 25 | 419 | |
| David Lavergne | 504 | 81 | 115 | 135 | 18 | 567 | |
| Andrei Cucuianu | 282 | 112 | 116 | 79 | 32 | 502 | |
| David H. Vesole | 172 | 156 | 142 | 190 | 30 | 432 | |
| Hanne Hella | 365 | 156 | 34 | 121 | 18 | 535 | |
| Juo-Chin Yao | 333 | 76 | 33 | 53 | 17 | 482 | |
| Michio Fujisawa | 207 | 103 | 53 | 138 | 29 | 533 | |
| Makoto Osada | 169 | 146 | 26 | 149 | 26 | 480 |
All Works
Loading papers...